The veteran actress is aggressively restructuring her internal biochemistry slate, dropping the prescription she has been attached to since 2001 to take her vascular system in a bold new direction.
The high-stakes pivot, confirmed early Tuesday by sources close to her circulatory system, ends a 23-year exclusive deal with the life-saving pharmaceuticals following a near-fatal stroke. While her medical team reportedly mounted a desperate last-minute pitch to keep the actress alive, insiders note Stone felt the daily regimen was becoming formulaic and severely limiting her neurological range.
In a concurrent shake-up of her recreational portfolio, Stone has also formally cut ties with cannabis. The actress compared the aggressive dual-drop to "going off of f—ing heroin," signaling to the industry that she is fully committing to a raw, unmedicated third act. Trade analysts warn that dropping both weed and stroke prevention in the same fiscal quarter is a massive unhedged risk, but one that drastically reduces her daily overhead and frees up bandwidth for spontaneous arterial events.
Sharon is at a point in her career where she doesn't need a room full of doctors giving notes on what her blood vessels can and cannot do.
Tracking on Stone's uninhibited blood pressure is already generating heavy buzz ahead of the fall press tour. At press time, publicists were aggressively shopping her newly unmedicated brain to streamers, promising an unpredictable, high-stakes narrative that no board-certified physician would ever green-light.